The CHN comparison seems to be an interesting one Dutch because I suspect we're following the same trajectory. If the instos missed the early uplift, they then bought in at the cap raise and that gave them enough shares to control the price because the super low daily volumes combined with only 25m free float SOI are easy to play with (as we saw in early January) They're in it to accumulate a large position at the lowest possible price (aren't we all!)
The thing I'd like all of you LTH to think about is what was missing from yesterday's announcement?
1. The re analysis of over limit assays discussed in Nov
2. The words supergene enrichment
3. The phosphorus assays
So if the re analysis over the over limit assays confirms supergene enrichment doesn't that totally change our calculations, particularly at depth? I'd like everyone's thoughts on this
The CHN comparison seems to be an interesting one Dutch because...
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add WA1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.88 |
Change
-0.720(4.93%) |
Mkt cap ! $900.3M | |||
| Open | High | Low | Value | Volume |
| $14.46 | $14.57 | $13.78 | $3.443M | 245.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.02 | 1200 | 1 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| WA1 (ASX) Chart |